A novel use of temozolomide in a patient with malignant prolactinoma

Journal of Clinical Neuroscience

Volumn 16, Issue 12, 2009, Pages 1694-1696

  Byrne, Stephen ^a   Karapetis, Chris ^a   Vrodos, Nick ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Malignant; Prolactinoma; Temozolomide

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; PROLACTIN; TEMOZOLOMIDE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; DIABETES INSIPIDUS; EXCISION; HEMIANOPIA; HUMAN; HYPOPHYSIS ADENOMA; MALE; MULTIPLE CYCLE TREATMENT; NERVE FIBER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SELLA TURCICA; SURGICAL APPROACH; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 70350728390     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.05.013     Document Type: Article

References (12)

1. Newlands E.S., Stevens M.F., Wedge S.R., et al. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23 (1997) 35-61
2. Neff L.M., Weil M., Cole A., et al. Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists. Pituitary 10 (2007) 81
3. Popadic A., Witzmann A., Buchfelder M., et al. Malignant prolactinoma: a case report and review of the literature. Surg Neurol 51 (1999) 47-54
4. Lubke D., and Saeger W. Carcinomas of the pituitary: definition and review of the literature. Gen Diagn Pathol 141 (1995) 81-92
5. Crusius P.S., Forcelini C.M., Mallman A.B., et al. Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens. Arquivos de Neuropsiquiatria 63 (2005) 864-869
6. Kars M., Roelfsma F., Romjin J.A., et al. Malignant prolactinoma: a case report and review of the literature. Eur J Endocrinol 155 (2006) 523-534
7. Ruebel K.H., Leontovich A.A., Jin L., et al. Patterns of gene expression in pituitary carcinomas and adenomas analysed by high-density oligonucleotide arrays, reverse transcriptase quantitative PCR and protein expression. Endocrine 29 (2006) 435-444
8. Spada A., Mantovani G., and Lanai A. Pathogenesis of prolactinomas. Pituitary 8 (2005) 7-15
9. Hurel S.J., Harris P.E., McNicol A.M., et al. Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression. J Clin Endocrinol Metab 82 (1997) 2962-2965
10. Fadul C.E., Kominsky A.L., Meyer L.P., et al. Long-term response of pituitary carcinoma to temozolomide. Report of two cases. J Neurosurg 105 (2006) 621-626
11. Kovacs K., Horvath E., Syro L.V., et al. Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings. Hum Pathol 38 (2007) 526
12. Perry M.C. The Chemotherapy Source Book. 2nd edition Vol. 308 (1997), Williams and Wilkins, Baltimore